Engineered for accuracy, reliability, and clinical-grade performance.
Bridging the gap between biotechnology innovation and large-scale industrial production.
Shenzhen BioX Medical Co., Ltd. is a professional manufacturer specializing in molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment. Established in 2017, the company is headquartered in Shenzhen, China, a leading center for biotechnology innovation.
With a modern manufacturing facility covering more than 9,000 square meters and a workforce of over 200 employees, BioX Medical is dedicated to the research, development, and supply of molecular diagnostic technologies worldwide.
Serving customers across Europe, North America, Asia-Pacific, the Middle East, Latin America, and Africa, we provide flexible OEM and ODM services for distributors and healthcare organizations.
Sqm Factory Space
Expert Employees
Export Countries
Founded Year
A deep dive into the industrial trends and macro-economic factors driving molecular diagnostics.
The global landscape for genetic testing systems factories has undergone a seismic shift in the last decade. As precision medicine transitions from a theoretical framework to a clinical standard, the demand for scalable, high-throughput genetic analysis platforms has skyrocketed. Today's "Smart Factories" in the biotechnology sector are no longer just assembly lines; they are integrated hubs of micro-fluidics engineering, software development, and biochemical expertise.
At BioX Medical, we recognize that Information Gain in the SEO context is mirrored by "Technical Gain" in the laboratory. Providing a 96-well thermal cycler is standard; providing a system with ±0.1°C uniformity across the entire block, integrated with AI-driven interpretation software, is where we provide competitive advantages for our partners.
The industrial status of genetic testing reflects a move toward Decentralization. While massive central labs still handle the bulk of population screening, there is an increasing user intent for "Point-of-Care" (POC) systems. This requires factories to innovate in miniaturization—creating portable liquid nitrogen generators and compact PCR units that maintain the integrity of clinical data without requiring a 100-square-meter footprint.
Furthermore, Genetic Testing Systems are now pivotal in agricultural breeding, forensic science, and oncology. Factories must now cater to diverse technical routes, including Next-Generation Sequencing (NGS) prep, Digital PCR (dPCR), and traditional Automated ELISA systems. This multidisciplinary approach ensures that a factory remains resilient against market shifts, providing solutions for both the current pathogen detection needs and the future of personalized genomic mapping.
Strategic Insight: The convergence of AI and robotics in our Shenzhen factory allows for a "Zero-Error" manufacturing protocol, ensuring that every Genetic Testing Lab RO Water Purifier meets the strict low-nuclease requirements essential for delicate genetic amplification.
Where is the genetic testing industry headed in 2025 and beyond?
The integration of the "Internet of Medical Things" (IoMT) into our Automatic Nucleic Acid Testing Systems allows for remote monitoring, proactive maintenance, and real-time data sync with hospital Information Systems (HIS).
Our research into Fast-Acting Nitrogen Liquefiers addresses the critical "Last Mile" problem in genetic sample preservation. Portable, high-efficiency liquid nitrogen solutions are becoming the backbone of field research and livestock breeding programs.
The Chromosome Karyotype Analysis System is moving toward deep-learning-based automated identification. Our future roadmap includes integrating NVIDIA-powered GPU processing into our digital imaging platforms for instant FISH CGH analysis.
Our systems are designed for versatility across multiple industrial and clinical domains.
From prenatal screening via karyotype analysis to rapid pathogen detection during public health crises, our PCR and ELISA platforms provide the high sensitivity required for medical-grade results.
Advanced liquid nitrogen systems allow for the cryopreservation of genetic material in livestock and plant species, supporting the global food security through precision breeding programs.
University labs and forensic departments utilize our thermal cyclers and RO water systems to ensure sample integrity and high-resolution genetic fingerprinting without contamination.
E-E-A-T principles in action: Reliability you can trust on every continent.
Shenzhen BioX Medical Co., Ltd. operates under the most stringent ISO 13485 quality management systems for medical devices. Every genetic testing system factory outlet we manage adheres to CE, FDA, and local regulatory requirements for the regions we serve.
Our systems undergo rigorous "Stress-Testing" in extreme laboratory environments to ensure that a Liquid Nitrogen Generator in the tropical climate of Southeast Asia performs with the same efficiency as one in a North American research center.
Expert answers for lab managers and procurement directors.
Our PC-96p series utilizes a gold-plated heating block for superior thermal conductivity and "Gradient" functionality, which allows for optimization of annealing temperatures in a single run, significantly reducing assay development time.
Our system integrates multi-stage reverse osmosis with specialized UV photo-oxidation and ultrafiltration (UF) modules designed specifically to degrade DNase and RNase, reaching a resistivity of 18.2 MΩ.cm.
Yes, our Portable Liquid Nitrogen Machines and Compact Generators are designed for "Plug-and-Play" operation, requiring only electrical power to extract nitrogen from the atmosphere, making them ideal for breeding sites without easy access to gas suppliers.
Typically, for bulk orders, our 9,000sqm factory can fulfill production within 4-6 weeks, including rigorous quality inspection and calibration before shipment.
Completing your laboratory infrastructure with specialized nitrogen and imaging tools.
Committed to advancing modern laboratory technologies through continuous innovation.
Supported by a multidisciplinary team of engineers, laboratory specialists, and quality management professionals, the company continuously invests in innovation and product development. Comprehensive quality control procedures are implemented throughout design, manufacturing, testing, and inspection processes to ensure consistent performance and compliance with international industry standards.
Shenzhen BioX Medical Co., Ltd. focuses on delivering reliable, scalable, and innovative diagnostic systems that support disease detection, genetic analysis, clinical research, and precision healthcare initiatives. Through continuous technological advancement and customer-oriented development, the company strives to contribute to the global evolution of molecular diagnostics and laboratory medicine.
BioX Medical
